2015
DOI: 10.1016/j.respol.2015.02.002
|View full text |Cite
|
Sign up to set email alerts
|

Does governmental venture capital spur invention and innovation? Evidence from young European biotech companies

Abstract: a b s t r a c tThis paper explores whether and how governmental venture capital investors (GVCs) spur invention and innovation in young biotech companies in Europe. To gauge invention we focus on the simple patent stock at the company level, while innovation is proxied by the citation-weighted patent stock. Our findings indicate that GVCs, as stand-alone investors, have no impact on invention and innovation. However, GVCs boost the impact of independent venture capital investors (IVCs) on both invention and in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

12
123
1
7

Year Published

2017
2017
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 192 publications
(143 citation statements)
references
References 72 publications
12
123
1
7
Order By: Relevance
“…This evidence is consistent with most of the literature on finance and innovation, for instance, studies of venture capital and innovation, which find that venture capital investments and the frequency with which firms use this type of selective and competitive external financial resource, are generally associated to high innovation potential (Casamatta, 2003;Arqué-Castells, 2012;Bertoni et al, 2015). However, the presence of adequate demand for innovative product is not necessarily guaranteed.…”
Section: Conclusion and Policy Implicationssupporting
confidence: 86%
See 2 more Smart Citations
“…This evidence is consistent with most of the literature on finance and innovation, for instance, studies of venture capital and innovation, which find that venture capital investments and the frequency with which firms use this type of selective and competitive external financial resource, are generally associated to high innovation potential (Casamatta, 2003;Arqué-Castells, 2012;Bertoni et al, 2015). However, the presence of adequate demand for innovative product is not necessarily guaranteed.…”
Section: Conclusion and Policy Implicationssupporting
confidence: 86%
“…VCs usually prefer to invest in firms with higher innovation potential, although not in basic research or at the beginning of the innovation cycle, confirming that potentially highly innovative firms are more in need of external finance. Other studies show that VC certification, which signals to the market the goodness of the innovation investment, significantly affects recurrent resort to venture capital financing (Bertoni et al, 2015). Overall, this literature finds that external finance is a necessary, but not sufficient condition to ensure successful innovation (Casamatta, 2003).…”
Section: Financing Constraints and Randd Investmentsmentioning
confidence: 98%
See 1 more Smart Citation
“…Scholarly evidence indicates that this is a sound decision. For example, Bertoni and Tykvova (2015) document a very positive innovation impact of GVC investments in European pharma and biotech start-ups, but only when the GVC investor enters a syndicate led by a private investor. When GVC investors invest on a stand-alone basis, this positive effect vanishes.…”
Section: An Overview and Comparison Of New Players In Entrepreneurialmentioning
confidence: 99%
“…In syndication with private VCs, six related peer-reviewed papers confirm a positive correlation with exits (Brander et al, 2014;, growth of portfolios (Grilli and Murtinu, 2014a;Grilli and Murtinu, 2014b), innovation (Bertoni and Tykvová, 2015) and staging (Brander et al, 2014). On the overview of previous research, it can be noted that many government VCs seem to contribute to less exits of portfolios.…”
Section: Do Government Venture Capitals Contribute To Their Portfolios?mentioning
confidence: 94%